Good short- and long-term efficacy with furazolidone in ulcers

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1992

Schlagwörter:	Adverse Effect Dopamine Relapse Rate Healing Rate Ulcer Healing

Anmerkung:	© Adis International Ltd 1992

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 859(1992), 1 vom: Okt., Seite 19-19
Übergeordnetes Werk:	volume:859 ; year:1992 ; number:1 ; month:10 ; pages:19-19

Links:	Volltext

DOI / URN:	10.2165/00128413-199208590-00036

Katalog-ID:	SPR036084816

Internformat


LEADER	01000caa a22002652 4500
001	SPR036084816
003	DE-627
005	20230519073145.0
007	cr uuu---uuuuu
008	201007s1992 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-199208590-00036 \|2 doi
035			\|a (DE-627)SPR036084816
035			\|a (SPR)00128413-199208590-00036-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Good short- and long-term efficacy with furazolidone in ulcers
264		1	\|c 1992
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1992
650		4	\|a Adverse Effect \|7 (dpeaa)DE-He213
650		4	\|a Dopamine \|7 (dpeaa)DE-He213
650		4	\|a Relapse Rate \|7 (dpeaa)DE-He213
650		4	\|a Healing Rate \|7 (dpeaa)DE-He213
650		4	\|a Ulcer Healing \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 859(1992), 1 vom: Okt., Seite 19-19 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:859 \|g year:1992 \|g number:1 \|g month:10 \|g pages:19-19
856	4	0	\|u https://dx.doi.org/10.2165/00128413-199208590-00036 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 859 \|j 1992 \|e 1 \|c 10 \|h 19-19

Indexfelder

matchkey_str	article:22306056:1992----::odhradogemfiayihuao
hierarchy_sort_str	1992
publishDate	1992
allfields	10.2165/00128413-199208590-00036 doi (DE-627)SPR036084816 (SPR)00128413-199208590-00036-e DE-627 ger DE-627 rakwb eng Good short- and long-term efficacy with furazolidone in ulcers 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1992 Adverse Effect (dpeaa)DE-He213 Dopamine (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Healing Rate (dpeaa)DE-He213 Ulcer Healing (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 859(1992), 1 vom: Okt., Seite 19-19 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:859 year:1992 number:1 month:10 pages:19-19 https://dx.doi.org/10.2165/00128413-199208590-00036 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 859 1992 1 10 19-19
spelling	10.2165/00128413-199208590-00036 doi (DE-627)SPR036084816 (SPR)00128413-199208590-00036-e DE-627 ger DE-627 rakwb eng Good short- and long-term efficacy with furazolidone in ulcers 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1992 Adverse Effect (dpeaa)DE-He213 Dopamine (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Healing Rate (dpeaa)DE-He213 Ulcer Healing (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 859(1992), 1 vom: Okt., Seite 19-19 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:859 year:1992 number:1 month:10 pages:19-19 https://dx.doi.org/10.2165/00128413-199208590-00036 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 859 1992 1 10 19-19
allfields_unstemmed	10.2165/00128413-199208590-00036 doi (DE-627)SPR036084816 (SPR)00128413-199208590-00036-e DE-627 ger DE-627 rakwb eng Good short- and long-term efficacy with furazolidone in ulcers 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1992 Adverse Effect (dpeaa)DE-He213 Dopamine (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Healing Rate (dpeaa)DE-He213 Ulcer Healing (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 859(1992), 1 vom: Okt., Seite 19-19 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:859 year:1992 number:1 month:10 pages:19-19 https://dx.doi.org/10.2165/00128413-199208590-00036 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 859 1992 1 10 19-19
allfieldsGer	10.2165/00128413-199208590-00036 doi (DE-627)SPR036084816 (SPR)00128413-199208590-00036-e DE-627 ger DE-627 rakwb eng Good short- and long-term efficacy with furazolidone in ulcers 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1992 Adverse Effect (dpeaa)DE-He213 Dopamine (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Healing Rate (dpeaa)DE-He213 Ulcer Healing (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 859(1992), 1 vom: Okt., Seite 19-19 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:859 year:1992 number:1 month:10 pages:19-19 https://dx.doi.org/10.2165/00128413-199208590-00036 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 859 1992 1 10 19-19
allfieldsSound	10.2165/00128413-199208590-00036 doi (DE-627)SPR036084816 (SPR)00128413-199208590-00036-e DE-627 ger DE-627 rakwb eng Good short- and long-term efficacy with furazolidone in ulcers 1992 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1992 Adverse Effect (dpeaa)DE-He213 Dopamine (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Healing Rate (dpeaa)DE-He213 Ulcer Healing (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 859(1992), 1 vom: Okt., Seite 19-19 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:859 year:1992 number:1 month:10 pages:19-19 https://dx.doi.org/10.2165/00128413-199208590-00036 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 859 1992 1 10 19-19
language	English
source	Enthalten in Inpharma weekly 859(1992), 1 vom: Okt., Seite 19-19 volume:859 year:1992 number:1 month:10 pages:19-19
sourceStr	Enthalten in Inpharma weekly 859(1992), 1 vom: Okt., Seite 19-19 volume:859 year:1992 number:1 month:10 pages:19-19
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Adverse Effect Dopamine Relapse Rate Healing Rate Ulcer Healing
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1992-10-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR036084816
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036084816</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519073145.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1992 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199208590-00036</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036084816</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199208590-00036-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Good short- and long-term efficacy with furazolidone in ulcers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1992</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1992</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adverse Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dopamine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Relapse Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Healing Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ulcer Healing</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">859(1992), 1 vom: Okt., Seite 19-19</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:859</subfield><subfield code="g">year:1992</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:19-19</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199208590-00036</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">859</subfield><subfield code="j">1992</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">19-19</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Good short- and long-term efficacy with furazolidone in ulcers Adverse Effect (dpeaa)DE-He213 Dopamine (dpeaa)DE-He213 Relapse Rate (dpeaa)DE-He213 Healing Rate (dpeaa)DE-He213 Ulcer Healing (dpeaa)DE-He213
topic	misc Adverse Effect misc Dopamine misc Relapse Rate misc Healing Rate misc Ulcer Healing
spellingShingle	misc Adverse Effect misc Dopamine misc Relapse Rate misc Healing Rate misc Ulcer Healing Good short- and long-term efficacy with furazolidone in ulcers
topic_unstemmed	misc Adverse Effect misc Dopamine misc Relapse Rate misc Healing Rate misc Ulcer Healing
topic_browse	misc Adverse Effect misc Dopamine misc Relapse Rate misc Healing Rate misc Ulcer Healing
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Good short- and long-term efficacy with furazolidone in ulcers
ctrlnum	(DE-627)SPR036084816 (SPR)00128413-199208590-00036-e
title_full	Good short- and long-term efficacy with furazolidone in ulcers
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1992
contenttype_str_mv	txt
container_start_page	19
container_volume	859
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-199208590-00036
title_sort	good short- and long-term efficacy with furazolidone in ulcers
title_auth	Good short- and long-term efficacy with furazolidone in ulcers
abstract	© Adis International Ltd 1992
abstractGer	© Adis International Ltd 1992
abstract_unstemmed	© Adis International Ltd 1992
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Good short- and long-term efficacy with furazolidone in ulcers
url	https://dx.doi.org/10.2165/00128413-199208590-00036
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-199208590-00036
up_date	2024-07-03T16:29:41.823Z
_version_	1803576076480282625
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036084816</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519073145.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1992 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199208590-00036</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036084816</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199208590-00036-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Good short- and long-term efficacy with furazolidone in ulcers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1992</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1992</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adverse Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Dopamine</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Relapse Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Healing Rate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ulcer Healing</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">859(1992), 1 vom: Okt., Seite 19-19</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:859</subfield><subfield code="g">year:1992</subfield><subfield code="g">number:1</subfield><subfield code="g">month:10</subfield><subfield code="g">pages:19-19</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199208590-00036</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">859</subfield><subfield code="j">1992</subfield><subfield code="e">1</subfield><subfield code="c">10</subfield><subfield code="h">19-19</subfield></datafield></record></collection>
score	7.399453

Nicht das Richtige dabei?

Schreiben Sie uns!

Good short- and long-term efficacy with furazolidone in ulcers

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?